Nortis, Inc.

20 employees

Nortis is developing the next generation of invitro systems that will allow scientists to better understand the causes of human diseases.

Basic info

biotechnology research

Organs-on-Chip

Biotechnology

Preclinical studies

OoC

Disease models

Tumor microenvironment models

Drug development

High Content Screening

Liver models

Tissue Engineering

Tissue models

Refine

Replace

Kidney models

Personalized medicine

Reduce

Contract research

3D cell culture

Medical

In-vitro testing

Microphysiological systems

Drug Screening

Oncology models

Biopharma

Cell based assays

Microfluidics

2012